Endacea

Developing A1 adenosine receptor (AR) antagonists as drug candidates for inflammation including sepsis and asthma; and renal impairment.

placeDurham, North Carolina, United States calendar_todayFounded 1995 language endacea.com

Innovation

15 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 999 times.

YearFilings
20121
20132
20141
20151
20181
20231

Investor mix

2 investors on record.

Investor typeCountShare
Accelerator & incubator150%
Other / undisclosed150%
Coming soon